NCT00006799View on ClinicalTrials.gov

Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 1, 2000

Primary Completion Date

September 6, 2002

Study Completion Date

September 6, 2002

Conditions
AnorexiaCachexiaHead and Neck CancerQuality of Life
Interventions
DRUG

megestrol acetate

PROCEDURE

quality-of-life assessment

Trial Locations (1)

27157-1082

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00006799 - Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer | Biotech Hunter | Biotech Hunter